Saquon Barkley has been running for big yards on the field this season, and now off the field the New York Giants rookie is running on Dunkin’. Dunkin’, the official coffee of the New York Giants, today announced a new partnership with running back Saquon Barkley. As part of a one-year promotional campaign, Barkley will now be featured in a series of Dunkin’ advertisements and promotions throughout the New York Metro Area.*
An instant fan favorite, Barkley will appear in a variety of Dunkin’ advertising, social media and live events beginning during the current NFL season. Kicking off with a series of video spots supporting Dunkin’s entirely new espresso experience, Barkley will promote various Dunkin’ food and beverages that keep Giants fans running all day long, such as the brand’s signature coffee & espresso beverages, baked goods and limited-time offer breakfast sandwiches.
To view the multimedia release go to:
https://www.multivu.com/players/English/8454451-dunkin-new-york-giants-running-back-saquon-barkley/
Cape Cod® Potato Chips joins in a culinary celebration as the official chip of the Lobster Rumble events hosted by Tasting Table. This summer, the combination of sumptuous lobster with the robust, full potato flavor and crunch of Cape Cod Potato Chips is sure to delight foodies from coast to coast.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/65575-eat-cape-cod-potato-chips/
Sabra® Dipping Company (www.sabra.com), makers of the country’s best-selling hummus and a wide variety of fresh dips and spreads, is kicking off the new year by inviting Americans to include hummus in their daily dipping activities - from casual weekday snacking to game-day dunking. While hummus has gained incredible popularity over the past decade, leading the country’s fastest growing dip category, there are still many Americans who have yet to taste it. Sabra’s new campaign, starring a hummus-obsessed Jeffrey Tambor, aims to introduce the delicious, unpretentious dip to future fans. The first ad in the national television campaign will debut in January to coincide with Super Bowl XLVIII, as Sabra continues its role as the Official Dips Sponsor of the NFL.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/65417-sabra-dipping-company-jeffrey-tambor-game-day-dipping-hummus-football
Bonefish Grill is turning National Martini Day into a month-long celebration in June. While the official day dedicated to America’s favorite cocktail is June 19th, the fresh fish experts are offering guests a flavorful array of hand-crafted martinis priced at $5 every Monday for the entire month.
Bonefish Grill martinis are already a favorite on the restaurant’s extensive bar menu – perfectly complementing their wood-grilled fresh fish and seasonal seafood offerings. In fact, the mighty martini is on-the-rise nationwide. A report published by the U.S. Beverage Alcohol Forum found that vodka – a main ingredient in martinis – accounts for over a third of all spirits consumed in the country, and that number continues to grow.
To view the multimedia release go to:
http://www.multivu.com/players/English/7848751-bonefish-grill-national-martini-month/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
